Search results
Piper Sandler cuts South State stock target, keeps Overweight rating By Investing.com
Investing.com· 9 hours agoDespite the downward revision, the firm maintains an Overweight rating on the stock. The adjustment...
1 Wall Street Analyst Thinks Alphabet Stock Is Going to $200. Is It a Buy?
Motley Fool via Yahoo Finance· 1 hour agoAlphabet also announced its first quarterly dividend of $0.20 per share and a new $70 billion share...
Stephens upgrades WW Grainger stock, citing path to premier industrial status By Investing.com
Investing.com· 11 hours agoMonday, WW Grainger Inc (NYSE:GWW) received an upgrade from Stephens, with its stock rating moving...
Apple Stock Out Of Favor, Hopes For Earnings Report Lift
Investor's Business Daily· 3 hours agoSpecifically, he expects a $90 billion increase to Apple's current stock buyback authorization and a...
Investing in Archer Aviation Inc
Knox Daily· 5 hours agoJP Morgan began covering ACHR with “an Overweight” recommendation on April 28, 2022. Deutsche Bank started covering the stock on April 11, 2022. It rated ACHR as “a Buy”.
Piper Sandler Reaffirms “Overweight” Rating for Microsoft (NASDAQ:MSFT)
ETF DAILY NEWS· 16 hours agoPiper Sandler reissued their overweight rating on shares of Microsoft (NASDAQ:MSFT – Free Report) in a research report sent to investors on Friday morning, Benzinga reports ...
Red Rock Resorts stock target cut on first quarter performance By Investing.com
Investing.com· 3 hours agoOn Monday, JPMorgan (NYSE:JPM) revised its stock price target for Red Rock Resorts (NASDAQ:RRR),...
Dolores Catania and Paul Connell Share Details About Recent Weight Loss
Reality Tea via Yahoo News· 2 hours agoDolores and Paul are reaching their health goals. The post Dolores Catania and Paul Connell Share...
Piper Sandler Reaffirms Overweight Rating for Bank of N.T. Butterfield & Son (NYSE:NTB)
ETF DAILY NEWS· 20 hours agoPiper Sandler restated their overweight rating on shares of Bank of N.T. Butterfield & Son (NYSE:NTB – Free Report) in a research note released on Thursday morning, Benzinga ...
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 9 hours agoUltimately, we believe combating obesity presents significant commercial opportunities for Novo Nordisk. On March 8, the FDA approved Wegovy to reduce...
